Publication | Closed Access
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer☆
53
Citations
24
References
2005
Year
Refractory Urothelial Cancer☆Urological ResearchUrologyGenitourinary CancerMedicineCancer TreatmentOncologyRadiation OncologyCancer ResearchSch 66336
| Year | Citations | |
|---|---|---|
Page 1
Page 1